Interim

QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System

VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase II clinical trial and a device study for the punctal plug delivery system. These studies are part of a development program that i...

Barry Lundquist Named Interim President of Council for Disability Awareness

PORTLAND, Maine, June 25 /PRNewswire/ -- The Council for Disability Awareness (CDA), a Portland, Maine-based not-for-profit organization dedicated to raising public awareness about the likelihood of becoming disabled and the need to prepare for the potential financial consequences, announced the a...

Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation

DOYLESTOWN, Pa., June 18 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY ) , www.quigleyco.com , today announced that Ted Karkus, Chairman of the Board of The Quigley Corporation, has been appointed Interim Chief Executive Officer by the Board of Directors of the Company. Mr...

T-System Releases Free Clinician Swine Flu Templates, Incorporating Updated CDC Interim Guidelines for Diagnosis and Treatment

Downloadable Templates Available Online for Emergency Clinicians and Other Healthcare Professionals DALLAS, April 30 /PRNewswire/ -- In response to the 2009 Swine Flu outbreak, T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation solutions...

School of Health Management Welcomes Interim Dean

After bidding farewell to its Dean of three years, the school welcomed Dr. Kimberly O'Reilly, D.H.Ed., M.S.W., as interim Dean. Kirksville, MO (PRWEB) April 23, 2009 -- The School of Health Management bid farewell to its dean of three years, Jon Persavich, Ph.D., on Dec...

Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide

TAMPA, Fla., April 15 /PRNewswire/ -- Sirion Therapeutics, Inc. announced today positive results from a planned interim analysis of its Phase II trial evaluating fenretinide for the treatment of geographic atrophy (GA) associated with age-related macular degeneration. This interim analysis was tri...

Harvest Technologies Announces Interim Study Results From Critical Limb Ischemia Trial in Chennai India

PLYMOUTH, Mass., April 1 /PRNewswire/ -- Harvest Technologies Corp. ( www.harvesttech.com ) announced today that the interim study report was completed for the first thirty (30) patients in the clinical trial of patients suffering with non-reconstructable critical limb ischemia due to advanced...

NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer

Brings Strong Industry and Executive Level Experience to Company FT. MYERS, Fla., March 16 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services, announced today that Douglas M. VanOort, 53 years old, has joined the Co...

NutraCea Names James C. Lintzenich As Interim CEO

Announces Resignation of Brad Edson PHOENIX, March 10 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB) nutrient research and technology, announced today that James C. Lintzenich, chairman of the Audit Committee has been appointed to...

Karmanos Cancer Institute Announces Interim Leadership

DETROIT, March 5 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute and Karmanos Cancer Center boards of directors today announced that effective immediately Ann G. Schwartz, Ph.D. has been appointed Interim President and Chief Executive Officer, and Paul Broughton has been appoi...

Interim in Medical Technology

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

Improvements in Systolic Blood Pressure and Triglycerides Also Observed NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ), and Alkermes, Inc. (Nasdaq: ALKS ) today announced long-term, interim results from the ...

Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting

ATLANTA, May 4 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that positive interim 12-month safety and efficacy results from the first ...

Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis

ROCKVILLE, Md., April 7 /PRNewswire/ -- Glycotex, Inc. today announced the completion of a scheduled interim analysis in a Phase II study evaluating the effect of investigational GLYC-101 gel on complete wound closure and cosmetic outcomes in cosmetic surgery patients undergoing carbon dioxide las...

Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results

- Lead Investigator Professor John F. Thompson Presented Results at The Sixth International Symposium on Melanoma and Other Cutaneous Malignancies in New York City - - Detailed Efficacy Data to be Presented at ASCO May 29-June 2, 2009 - KNOXVILLE, Tenn., March 16 /PRNewswire-FirstCall/...

Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study

ATLANTA, March 12 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim 12-month safety and efficacy results from the first human ...

Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data

INTERIM DATA FROM PHASE 3 CLINICAL TRIAL FOR NATURLOSE(R) ANTICIPATED BY FALL BETHESDA, Md., March 11 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology and a provider of technical and regulatory consulting services to food, supplement, biotechnolo...

Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis

- Interim Findings To Be Presented in a Poster Session at the 67th Annual Meeting of the American Academy of Dermatology - SAN FRANCISCO, March 6 /PRNewswire/ -- Galderma Laboratories, L.P. today announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex ...

Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia

- 31% COMPLETE RESPONSE RATE - MEDIAN SURVIVAL OF 10.5 MONTHS IN COMPLETE RESPONDERS - FINAL DATA TARGETED FOR 2009 ASH ANNUAL MEETING SOUTH SAN FRANCISCO, Calif., March 3 /PRNewswire-FirstCall/ -- Hana Biosciences (Nasdaq: HNAB ) today announced new positive preliminary efficacy ...

Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis

EMERYVILLE, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) today announced that an independent Data Safety Monitoring Board (DSMB) has determined that the current clinical trials of Viprinex(TM) for the treatment of acute ischemic stroke are...

Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients

SAN FRANCISCO, Dec. 8 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN ) today released updated results from the ongoing, open-label extension study of the long-term safety and efficacy of Nplate(TM) (romiplostim) in adult patients with chronic immune thrombocytopenic purpura (ITP). Chronic IT...

More>>

Interim in Medical Products

Modular Cardiac Cath Labs

Description:... MDI will work with your facility to determine the best interim lab to fit your needs and your site....
Company:Modular Devices, Incorporated

Interim Mobile Cardiac Catheterization and Angiography Services

Description:...nt and provides applications training to your hospital staff. MedCath Diagnostics gives your hospital a cost-effective strategy for meeting your interim challenges. When your hospital's reputation is on the line, turn to our professionals to help put a permanent solution to your temporary needs. ...
Company:MedCath Corporation

Advia WorkCell CDX Modular Automation

Features:...anage STAT samples independently from routine samples Review and edit results, order repeat and/or reflex tests, auto-validate results and provide interim LIS backup with ADVIA CentraLink data management system Improved Quality of Services - Reduce errors and costs while ensuring continuou...
Company:Siemens Medical Solutions Diagnostics

Interim in Medical Dictionary

Diastole

..... Today, a much expanded Diastole is available for a wide variety of UMKC ... Diastole , pronounced (dy-AS-tuh-lee), is a medical term for the interim between ... Who can use Diastole ? ... What kind of events can be held at Diastole ? ... Diastole does not provide on-site catering. ... O...

Bioterrorism

...n a naturally-occurring or in a human-modified form. Includes information on bioterrorism , chemical agents, and natural disasters. Also features interim notification procedures for public health department leaders, ... Information on terrorism and public health. Provided by the Centers for Diseas...

Anastomosis

...omosis and is complete in two ... The superior cavopulmonary anastomosis is the first of two ... Bidirectional cavopulmonary anastomosis as interim palliation for high-risk Fontan candidates. ... Anastomosis is when 2 structures are surgically connected. ... A pathological (caused by disease...

Interim in Biological News

University of Minnesota research leads to new technology to protect human health

... small but strategic investment in scientific research can make a big difference," says Robert P. Elde, dean of the College of Biological Sciences and interim director of the Biotechnology Institute. Melamine was originally used to make durable plastic for dishes and countertops. It is also a widely used...

Penn-Wistar team gains insight into HIV vaccine failure

...asibility of HIV-1 vaccines. The findings were published on-line July 20 in Nature Medicine . The phase II STEP vaccine trial was stopped after an interim analysis showed no efficacy in preventing HIV infection in at-risk individuals. It was noted that a subset of participants who had previous immunity i...

$20 million NIH grant to transform clinical research at UIC

...e the UIC center "unique as a statewide translational science program," he said. "This is an important award for UIC," said Dr. Larry Danziger, UIC interim vice chancellor for research. "We are excited about the ways in which this award will facilitate increased collaborations among our basic science and ...

Civil engineers name NJIT's John Schuring Educator of Year

... the NJIT Hydraulics and Hydrogeology Laboratory, and also served as an academic administrator for eight years, first as department chair and later as interim dean of the Newark College of Engineering. Schuring is a dedicated teacher and mentor. He was recently designated a University Master Teacher and...

Civil engineers name NJIT's John Schuring Educator of Year Award

... the NJIT Hydraulics and Hydrogeology Laboratory, and also served as an academic administrator for eight years, first as department chair and later as interim dean of the Newark College of Engineering. Schuring is a dedicated teacher and mentor. He was recently designated a University Master Teacher and...

Major funding to help cut CO2 emissions

...o reducing carbon emissions by 80 per cent by 2050. In the short-term the Government advisory body, the Committee for Climate Change, has suggested an interim cut of at least 34 per cent by 2020. David Delpy, EPSRC Chief Executive, said: "This illustrates the enormous benefit that can arise from strategi...

Live webcasting of global engineering summit

...that detailed how engineering has and will play a critical part in resolving major societal issues. Participants will include A. Paul Alivisatos, interim director, Lawrence Berkeley National Laboratory; Robert Socolow, professor, Princeton University; Annie Anton, professor, North Carolina State Univers...

Ocean research officials hail completion of modernization for US scientific ocean drilling vessel

...SF congratulates all involved in the successful refit and modernization of this major research platform." Steven Bohlen of Texas A&M University and interim director of science services at IODP, remarked, "Speaking from close ties with the community of scientists involved with many aspects of IODP's work, ...

Researchers to use K-State's BSL-3 Lab for $1 million study of fungus threatening wheat crops

...her a lab where the plants and fungus can be grown and stored, and where we can work with the fungus and destroy it after testing." Beth Montelone, interim scientific director of the Biosecurity Research Institute, said, "We are very pleased that Dr. Valent and her colleagues will be bringing their wheat ...

Purdue study suggests warmer temperatures could lead to a boom in corn pests

... "Our projections showed all of the species studied spreading into agricultural areas where they currently are not endemic," said Diffenbaugh, who is interim director of the Purdue Climate Change Research Center. "The greatest potential range expansion was seen with the corn earworm, which is known to infes...

Interim in Biological Technology

ParagonRx Files with FDA REMS Panel Interim Analysis for Opioid Drugs Study

WILMINGTON, Del., July 15 /PRNewswire/ -- ParagonRx, a healthcare consulting leader in risk management and the appropriate use of drugs, has filed its interim analysis of a study that shows how its proprietary approach to risk management can help manufacturers of opioid drugs meet FDA standar...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

HORSHOLM, Denmark, July 14 /PRNewswire/ -- The Board of Directors of Santaris Pharma has approved the Interim Report for the period 1 January to 30 June 2009. - The loss after tax realised in the 2nd quarter of 2009 was 21,6m DKK (2,9m EUR) compared to 29,8m DKK (4,0m EUR) in the...

Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion

EXTON, Pa., June 19 /PRNewswire/ -- Isolagen(TM), Inc. announced on June 16, 2009, that the Company and Isolagen Technologies, Inc., the Company's wholly owned subsidiary, each filed a voluntary petition for reorganization under chapter 11 of the United States Bankruptcy Code in the United States ...

Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009

KVISTGAARD, Denmark, April 28 /PRNewswire-FirstCall/ -- Yesterday Bavarian Nordic Announced its Interim Results for the First Quarter of 2009 - Positive Developments in the Biodefence and Cancer Business Areas - End of Phase II Meeting Lays Down Pathway for the Licensure o...

Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer

NEW YORK, April 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced the appointment of Michael P. Tarnok to be its interim Chairman and Chief Executive Officer, replacing Michael S. Weiss, effective immediately. Mr. Tarnok, age 54, has served on Ker...

INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

-- Results from first low-dose cohorts plus data from subsequent higher-dose cohorts to be presented at EASL -- BRISBANE, Calif., March 18 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that an abstract from the clinical study of ITMN-191 (R7227) in combinatio...

Results of First Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial: Continuation of the Trial is Futile

NOVATO, Calif., Feb. 12 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that in the first interim efficacy analysis (IEA) for the Riquent(R) Phase 3 ASPEN trial, the Independent Data Monitoring Board (DMB) determined that the continuation of the trial i...

Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data

CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that an oral presentation covering the interim results of a U.S. Phase II trial investigating intravenous REOLYSIN(R) in patients with bone and soft tissue sarcomas metastatic to the lung ...

Misonix Announces Interim Distribution Agreement for Italy

FARMINGDALE, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has entered into an interim distributi...

Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure

SAN FRANCISCO, Oct. 14 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), today announced interim data from its multi-center, open-label Phase 2a clinical study of CD-NP, a novel chimeric natriuretic peptide, in patients hospitalized for acute heart failure. -- Statistica...

Interim in Biological Dictionary

Stomach

...rption of nutrients ... In anatomy, the stomach is a hollow muscular organ of the gastrointestinal tract ... The stomach serves as a sac for interim food storage and it also initiates the ... Organ Stomach including diseases and disorders affecting the Stomach organ or body system. ... The...

Microbiology

...gy . The voice of Microbiology in Europe. ... European Declaration for Microbiology . Organisation (Who is Who) History. Member Societies ... As interim Department Head of Microbiology at Montana State University, I am ... The discipline of microbiology is diverse, and the job opportunities for ......